Accidentally Injected Wegovy Into Muscle: What It Means and What to Do

Why does the injection site actually matter for Wegovy?

Semaglutide is not a medicine that works like a painkiller you swallow, its absorption profile depends entirely on where it lands. When a dose sits in subcutaneous tissue, a depot forms. The medicine is released slowly and steadily into the bloodstream over the course of the week, which is exactly why Wegovy is a once-weekly injection rather than a daily one. Muscle tissue has a richer blood supply than subcutaneous fat. If you are wondering what happens if you inject Wegovy into a muscle, the short answer is that the depot can disperse more quickly, and the slower, controlled release the formulation is designed for may be compromised.

In practice this is most likely to mean a faster initial rise in drug levels, which can translate to more pronounced nausea, quicker satiety, or a more intense version of the usual early side effects. It is a common misconception that injecting deeper is somehow better, that more muscle equals faster weight loss. It does not. The therapeutic effect of Wegovy comes from sustained plasma levels, not a spike. A sharper rise followed by a faster fall is simply a less stable delivery of the same dose, with more discomfort and no clinical gain. Our guide on injecting Wegovy into muscle explains in detail why the subcutaneous layer, rather than muscle tissue, is the correct target for reliable absorption.

For a fuller overview of the correct approach, our guide on how Wegovy is injected covers site selection, angle, and the pinch technique in detail.

What might you actually notice if Wegovy was injected into muscle?

Many people who accidentally inject into muscle notice nothing unusual at all, particularly if the error is marginal, the boundary between deep subcutaneous tissue and superficial muscle is not always obvious, especially at the abdomen. When something is noticeable, the most commonly reported experiences are:

Localised soreness or bruising at the injection site, more pronounced than usual. A faster onset of nausea or reduced appetite in the first day or two after the dose. Occasionally, a brief sensation of pain or pressure at the moment of injection, different from the mild sting of a subcutaneous dose.

None of these are unique to intramuscular injection, they can occur with correct technique too, especially early in treatment or after a dose increase. What you are watching for is anything more severe: intense abdominal pain that spreads to the back, with or without vomiting, is the symptom pattern associated with acute pancreatitis, a known but uncommon risk with GLP-1 medicines flagged in the MHRA Drug Safety Update, January 2026. That warrants urgent medical attention regardless of injection technique. Severe allergic reaction, chest pain, or signs of dehydration from persistent vomiting also require prompt help, call 111 or 999 as appropriate.

If you want to understand the broader picture of what can happen when the injection goes to the wrong depth, our page on what happens if you accidentally inject Wegovy into muscle goes into more detail on the pharmacokinetic side.

Which sites are most likely to result in an accidental intramuscular injection?

The upper arm is the site where this mistake happens most often, and for a straightforward reason: the subcutaneous layer over the deltoid muscle is thinner than at the abdomen or outer thigh, particularly in people with lower body fat. Standard pen needles (typically 4mm to 8mm) are designed with this variation in mind, but technique still matters. Injecting without pinching the skin, or pressing the pen too firmly into the surface, can push the needle tip past the subcutaneous layer.

The outer thigh carries a reasonable fat layer in most people and is generally the most forgiving site when the abdomen is unavailable. The abdomen, at least 5cm from the navel, remains the most predictable site for the majority of people.

Rotating between all three sites each week, as recommended, is not just about skin comfort. It prevents the formation of lipohypertrophy, thickened, lumpy tissue that absorbs medicine inconsistently. Our note on Wegovy pen volume and administration touches on why consistent tissue quality matters for reliable dosing. If you have accidentally injected semaglutide into muscle, our dedicated page explains exactly where the anatomical boundary sits and what to do next.

How do you correct technique to prevent this happening again?

The adjustment is straightforward. Pinch a fold of skin firmly between your thumb and two fingers before pressing the pen down, this lifts the subcutaneous layer away from the muscle beneath it. Hold the pen at 90 degrees to the skin surface and press steadily. On the abdomen and outer thigh in most adults, a 4mm needle at 90 degrees with a proper pinch will reliably stay subcutaneous. On the upper arm, either ask someone to help with the pinch, or choose a different site until your technique is confident.

Check that you are not pressing the pen too hard into your skin before activating it. Compressing the tissue removes the very layer you are trying to inject into. Light contact, then press the button, that sequence matters.

If your prescriber or our clinical team has not yet walked you through technique in detail, that conversation is worth having. The Patient Information Leaflet included with every Wegovy pen also illustrates the correct angle and pinch, it is worth re-reading even if you have been injecting for a while. Our prescribers are available through our support team seven days a week if you have questions specific to your situation.

For those considering starting Wegovy and weighing up the full picture (including cost alongside clinical support) our weight-loss treatment overview sets out what private treatment through a regulated pharmacy actually involves.